ClinicalTrials.Veeva

Menu

Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Hanmi Pharmaceutical logo

Hanmi Pharmaceutical

Status and phase

Completed
Phase 2

Conditions

Low Back Pain

Treatments

Drug: Epirisone 50mg or placebo TID

Study type

Interventional

Funder types

Industry

Identifiers

NCT01806818
HM-EPAC-201

Details and patient eligibility

About

Multi-center Study to Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients during 7 days.

Enrollment

98 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
  • 20≤ age ≤60
  • A patient has symptom of acute low back pain
  • 4≤ VAS

Exclusion criteria

  • Subjects who cannot prohibit anti-inflammatory drug, painkiller or muscle relaxants during clinical trial
  • Chronic rheumatoid arthritis patients
  • Patients having a medical history of hypersensitivity to Eperisone Hydrochloride
  • Subject having a hereditary problem such as galactose intolerance, Lapp lactase deficiency, or glucose galatose malabsorption
  • Participation in other studies before 60 days of first dosing
  • Female patients having positive pregnancy test, lactating women,planning pregnancy during clinical trial
  • Inadequate subject for the clinical trial by the investigator's decision

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

98 participants in 3 patient groups, including a placebo group

Eperisone 50mg BID
Experimental group
Description:
Administrate Eperisone 50mg tablet after the breakfast and dinner, and pacebo tablet after the lunch for 7 days
Treatment:
Drug: Epirisone 50mg or placebo TID
Epirisone 50mg TID
Experimental group
Treatment:
Drug: Epirisone 50mg or placebo TID
Placebo comparator
Placebo Comparator group
Treatment:
Drug: Epirisone 50mg or placebo TID

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems